Kolinsky Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,651
Closed -$211K 157
2024
Q1
$211K Sell
2,651
-664
-20% -$50.7K 0.16% 134
2023
Q4
$262K Sell
3,315
-81
-2% -$5.76K 0.23% 112
2023
Q3
$237K Buy
3,396
+267
+9% +$18.9K 0.24% 108
2023
Q2
$215K Sell
3,129
-140
-4% -$9.96K 0.2% 122
2023
Q1
$243K Sell
3,269
-529
-14% -$44.4K 0.26% 104
2022
Q4
$354K Buy
3,798
+257
+7% +$24.8K 0.4% 59
2022
Q3
$338K Buy
3,541
+38
+1% +$3.76K 0.42% 53
2022
Q2
$325K Buy
3,503
+315
+10% +$30.7K 0.38% 59
2022
Q1
$323K Sell
3,188
-231
-7% -$24.3K 0.32% 70
2021
Q4
$353K Buy
+3,419
New +$316K 0.33% 76

Other funds holding CVS

Kolinsky Wealth Management's CVS Position: Q2 2024 in Review

Kolinsky Wealth Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,651 shares — an estimated $211K sold.

Kolinsky Wealth Management first reported a position in CVS in Q4 2021 and held it in 10 quarters. The position peaked at $354K in Q4 2022. 1,914 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Kolinsky Wealth Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Kolinsky Wealth Management sold 2,651 CVS Health shares in Q2 2024, an estimated $211K.
  • Kolinsky Wealth Management first reported a position in CVS Health in Q4 2021 and held it in 10 quarters.
  • Kolinsky Wealth Management's CVS Health position peaked at $354K in Q4 2022.
  • 1,914 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Kolinsky Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.